| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.79B | -13.2% |
| Cost of Revenue | $1.04B | -11.0% |
| Gross Profit | $750.4M | -16.0% |
| R&D Expense | $16.9M | +15.8% |
| SG&A Expense | $587.5M | +6.9% |
| Operating Income | -$14.9M | -116.5% |
| Interest Expense | $122.8M | +16.8% |
| Pre-tax Income | -$309.2M | -1676.6% |
| Income Tax | $18.6M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $59.7M | -86.8% |
| Accounts Receivable | $207.2M | -34.9% |
| Inventory | $571.2M | -22.8% |
| Current Assets | $964.8M | -39.8% |
| Total Assets | $3.30B | -13.6% |
| Current Liabilities | $2.43B | +679.0% |
| Long-term Debt | $1.77B | +6.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$151.1M | -293.5% |
| Capital Expenditures | $56.7M | +1.7% |
| Investing Cash Flow | -$422.4M | -174.0% |
| Financing Cash Flow | $184.1M | +170.7% |
| Free Cash Flow | -$207.8M | -1031.6% |
| -12.7% |
| Net Income | -$208.9M | -184.8% |
| EPS (Basic) | -$3.83 | -647.1% |
| EPS (Diluted) | -$3.83 | -255.7% |
| Total Liabilities |
| $2.77B |
| +20.4% |
| Stockholders' Equity | $678.6M | -48.9% |